11:30 AM - 12:00 PM ET
The radiopharma boom
Radiopharmaceuticals continue to grow in popularity. Major drugmakers are making bets in the space, both in medicines — which take radiation therapy directly into cancer cells — and in diagnostics. Join our experts to discuss the latest clinical findings in the space, the main challenges in this therapeutic approach, and how various pharma companies are positioning themselves in the area.